aTYR PHARMA INC
Developing novel medicines for fibrosis and inflammation using tRNA synthetase biology.
ATYR | US
Overview
Corporate Details
- ISIN(s):
- US0021202025
- LEI:
- Country:
- United States of America
- Address:
- 10240 SORRENTO VALLEY ROAD, 92121 SAN DIEGO
- Website:
- https://www.atyrpharma.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
aTyr Pharma, Inc. is a clinical-stage biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological pathways. The company leverages its proprietary platform and deep understanding of tRNA synthetase biology, an approach it calls 'Evolutionary Intelligence,' to translate the extracellular signaling functions of these proteins into potential therapies. Its primary focus is on developing first-in-class product candidates for the treatment of diseases characterized by fibrosis and inflammation.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all aTYR PHARMA INC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for aTYR PHARMA INC
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for aTYR PHARMA INC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
